Careen Lowder, MD, PhD

Article Type

Article

Changed

Mon, 09/10/2018 - 08:44

Display Headline

Uveitis in the internist's office: Are a patient's eye symptoms serious?

Author(s)

Rula A. Hajj-Ali, MD

Careen Lowder, MD, PhD

Brian F. Mandell, MD, PhD

Article PDF

content_72_329.pdf

Author and Disclosure Information

Rula A. Hajj-Ali, MD
Department of Rheumatic and Immunologic Disease, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation

Careen Lowder, MD, PhD
Cole Eye Institute, The Cleveland Clinic Foundation

Brian F. Mandell, MD, PhD
Vice-Chairman of Medicine for Educational Affairs; Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation; Editor-in-Chief, Cleveland Clinic Journal of Medicine

Address: Brian Mandell, MD, PhD, Vice-Chairman of Medicine for Educational Affairs, NA20, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mandelb@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Issue

Cleveland Clinic Journal of Medicine - 72(4)

Publications

Cleveland Clinic Journal of Medicine

Topics

Infectious Diseases

Page Number

329-339

Read more about Uveitis in the internist's office: Are a patient's eye symptoms serious?

Sections

Reviews

Author(s)

Rula A. Hajj-Ali, MD

Careen Lowder, MD, PhD

Brian F. Mandell, MD, PhD

Author(s)

Rula A. Hajj-Ali, MD

Careen Lowder, MD, PhD

Brian F. Mandell, MD, PhD

Author and Disclosure Information

Rula A. Hajj-Ali, MD
Department of Rheumatic and Immunologic Disease, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation

Careen Lowder, MD, PhD
Cole Eye Institute, The Cleveland Clinic Foundation

Brian F. Mandell, MD, PhD
Vice-Chairman of Medicine for Educational Affairs; Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation; Editor-in-Chief, Cleveland Clinic Journal of Medicine

Address: Brian Mandell, MD, PhD, Vice-Chairman of Medicine for Educational Affairs, NA20, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mandelb@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Rula A. Hajj-Ali, MD
Department of Rheumatic and Immunologic Disease, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation

Careen Lowder, MD, PhD
Cole Eye Institute, The Cleveland Clinic Foundation

Brian F. Mandell, MD, PhD
Vice-Chairman of Medicine for Educational Affairs; Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, The Cleveland Clinic Foundation; Editor-in-Chief, Cleveland Clinic Journal of Medicine

Address: Brian Mandell, MD, PhD, Vice-Chairman of Medicine for Educational Affairs, NA20, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mandelb@ccf.org

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF

content_72_329.pdf

Article PDF

content_72_329.pdf

Issue

Cleveland Clinic Journal of Medicine - 72(4)

Issue

Cleveland Clinic Journal of Medicine - 72(4)

Page Number

329-339

Page Number